articleClinical Infectious DiseasesNov 17, 2003BRONZE OA

Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent Adults

McMaster University · Johns Hopkins University · +3 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Recent antibiotic therapy b A respiratory fluoroquinolone c alone, an advanced macrolide d plus high-dose amoxicillin, e or an advanced macrolide plus high-dose amoxicillin-clavulanate f Comorbidities (COPD, diabetes, renal or congestive heart failure, or malignancy) No recent antibiotic therapy An advanced macrolide d or a respiratory fluoroquinolone Recent antibiotic therapy A respiratory fluoroquinolone c alone or an advanced macrolide plus a b-lactam g Suspected aspiration with infection Amoxicillin-clavulanate or clindamycin Influenza with bacterial superinfection A b-lactam g or a respiratory fluoroquinolone Inpatient Medical ward No recent antibiotic therapy A respiratory fluoroquinolone alone or an…

Citation impact

1,013
total citations
FWCI
90.58
Percentile
100%
References
254
Citations per year

Authors

6

Topics & keywords

Keywords
  • Medicine
  • Community-acquired pneumonia
  • Pneumonia
  • Empiric therapy
  • Intensive care medicine
  • MEDLINE
  • Family medicine
  • Alternative medicine
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.